Key Points
- Celia Baxter purchased 1,728 shares of Genus (LON:GNS) on Feb 27 at an average price of GBX 2,893, a transaction totaling £49,991.04.
- Analysts are broadly positive: three recent "Buy" ratings and an average price target of GBX 3,216.67, versus the market open around GBX 2,915, implying potential upside.
- Financial snapshot: Genus has a market cap of £1.94bn but a high valuation (P/E ~100.87) with a low net margin (1.18%) and modest ROE (1.41%), indicating stretched earnings relative to price.
Genus plc (LON:GNS - Get Free Report) insider Celia Baxter purchased 1,728 shares of the firm's stock in a transaction on Friday, February 27th. The shares were purchased at an average cost of GBX 2,893 per share, for a total transaction of £49,991.04.
Genus Stock Performance
LON:GNS opened at GBX 2,915 on Friday. The firm has a 50 day simple moving average of GBX 2,845.83 and a 200-day simple moving average of GBX 2,648.45. The company has a debt-to-equity ratio of 53.12, a current ratio of 1.80 and a quick ratio of 1.08. The firm has a market cap of £1.94 billion, a PE ratio of 100.87, a P/E/G ratio of 2.87 and a beta of 0.37. Genus plc has a 1-year low of GBX 1,548 and a 1-year high of GBX 3,220.
Genus (LON:GNS - Get Free Report) last announced its earnings results on Thursday, February 26th. The company reported GBX 60.80 earnings per share (EPS) for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. On average, equities analysts expect that Genus plc will post 70.9644323 EPS for the current year.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the company. Berenberg Bank reiterated a "buy" rating and set a GBX 3,350 target price on shares of Genus in a research report on Thursday, February 5th. Shore Capital Group reaffirmed a "buy" rating and set a GBX 3,000 price objective on shares of Genus in a research note on Friday, January 16th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of Genus from GBX 3,100 to GBX 3,300 and gave the stock a "buy" rating in a research report on Friday, January 16th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of "Buy" and an average price target of GBX 3,216.67.
Get Our Latest Stock Analysis on Genus
Genus Company Profile
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
